Analysis: Innoscience-Infineon clash shows China's courts becoming a weapon in the global GaN race

The Innoscience vs. Infineon dispute signals Chinese courts’ shift from passive adjudication to active rule-setting in global GaN technology governance. Technically, enforcement of the injunction could force redesigns of driver circuits and packaging architectures, disrupting established GaN-on-Si integration roadmaps. Compliance costs will surge as multinationals must now embed local IP review units in China and diversify supply chains to mitigate single-point legal exposure. Competitors like STMicroelectronics and Navitas may accelerate partnerships with Chinese foundries to gain judicial leeway, while Infineon might delay CoolGaN rollouts across Asia-Pacific. Over the next 12–24 months, this 'jurisdictional preemption' will fragment global GaN patent ecosystems: Western firms will tighten cross-licensing alliances, while China leverages standard-essential patents (SEPs) to erect technical moats. This is not merely litigation—it’s a geopolitical contest for dominance in next-generation power semiconductors.